Pharmaceutical Research and Manufacturers of America IEC

Sacramento, CA 95814-2809
Ballot Initiative
Political Committees
back to directoryBack to Directory

Related Posts:

Stephen J. Ubl, CEO of the Pharmaceutical Research and Manufacturers of America - Provided photo
PhRMA warns of cancer drug markups, 340B program profiteering affecting Pennsylvania

January 13, 2026

The Pharmaceutical Research and Manufacturers of America (PhRMA) announced that hospital systems are marking up decades-old cancer drugs significantly above Medicare rates.

Read more →
Molly Jenkins, PhRMA Senior Director of Public Affairs - Provided photo
PhRMA Senior Director Jenkins on 340B misuse affecting Pennsylvania: ‘Tax-exempt hospitals exploit the 340B program as a profit center’

November 26, 2025

Molly Jenkins, Senior Director of Public Affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA), said that the 340B program is increasing Medicare costs by blocking rebates and worsening taxpayer burdens — an issue garnering attention in Pennsylvania.

Read more →

Top Stories: